Correlation between LSP1 polymorphisms and the susceptibility to breast cancer

被引:0
作者
Chen, Hai [1 ]
Qi, Xiaodong [1 ]
Qiu, Ping [1 ]
Zhao, Jiali [1 ]
机构
[1] Beijing Mil Command, Gen Hosp, Dept Galactophore, Beijing, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 05期
关键词
LSP1; breast cancer; polymorphisms; LEUKOCYTE-SPECIFIC PROTEIN-1; ASSOCIATION; REGULATOR; MORTALITY; RISK;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The present study aimed at assessing the relationship between Leukocyte-specific protein 1 gene (LSP1) polymorphisms (rs569550 and rs592373) and the pathogenesis of breast cancer (BC). Methods: 70 BC patients and 72 healthy subjects were enrolled in the study. Rs569550 and rs592373 polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Odds ratio (OR) with 95% confidence interval (CI) were calculated by the chi-squared test to assess the relationship between LSP1 polymorphisms and BC risk. Linkage disequilibrium (LD) and haplotypes were also analyzed by HaploView software. Results: Genotype distribution of the control was in accordance with Hardy-Weinberg equilibrium (HWE). The homozygous genotype TT and T allele of rs569550 could significantly increase the risk of BC (TT vs. GG: OR=3.17, 95% CI=1.23-8.91; T vs. G: OR=1.63, 95% CI=1.01-2.64). For rs592373, mutation homozygous genotype CC and C allele were significantly associated with BC susceptibility (CC vs. TT: OR=4.45, 95% CI=1.38-14.8; C vs. T: OR=1.70, 95% CI=1.03-2.81). LD and haplotypes analysis of rs569550 and rs592373 polymorphisms showed that T-C haplotype was a risk factor for BC (T-C vs. G-T: OR=1.74, 95% CI=1.04-2.92). Conclusion: LSP1 rs569550 and rs592373 polymorphisms are both risk factors for BC.
引用
收藏
页码:5798 / 5802
页数:5
相关论文
共 50 条
  • [21] Polymorphisms in tissue inhibitors of metalloproteinases-2 and-3 and breast cancer susceptibility and survival
    Peterson, Neeraja B.
    Beeghly-Fadiel, Alicia
    Gao, Yu-Tang
    Long, Jirong
    Cai, Qiuyin
    Shu, Xiao-ou
    Zheng, Wei
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 844 - 850
  • [22] Caspase 9 promoter polymorphisms confer increased susceptibility to breast cancer
    Theodoropoulos, George E.
    Michalopoulos, Nikolaos V.
    Pantou, Malena P.
    Kontogianni, Panagiota
    Gazouli, Maria
    Karantanos, Theodoros
    Lymperi, Maria
    Zografos, George C.
    CANCER GENETICS, 2012, 205 (10) : 508 - 512
  • [23] Association between TCF7L2 polymorphisms and breast cancer susceptibility: a meta-analysis
    Wang, Feng
    Jiang, Lixin
    Li, Jianlin
    Yu, Xiao
    Li, Mingchuan
    Wu, Guochang
    Yu, Zhenyu
    Zhou, Kai
    Chu, Haidi
    Zhai, Huiyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9355 - 9361
  • [24] Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population
    Jin, Min
    Lu, Fengke
    Li, Xi
    Zhou, Wei
    Li, Sihui
    Jiang, Yanting
    Wu, Huiling
    Wang, Jian
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [25] Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women
    Lajin, Bassam
    Sakur, Amir Alhaj
    Alachkar, Amal
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 611 - 619
  • [26] Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility
    Lesicka, Monika
    Jablonska, Ewa
    Wieczorek, Edyta
    Peplonska, Beata
    Gromadzinska, Jolanta
    Seroczynska, Barbara
    Kalinowski, Leszek
    Skokowski, Jaroslaw
    Reszka, Edyta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [27] Is there a relation between genetic susceptibility with cancer? A study about paraoxanase (PON1) enzyme activity in breast cancer cases
    Kaya, Mustafa Oguzhan
    Sinan, Selma
    Guler, Ozen Ozensoy
    Arslan, Oktay
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 1349 - 1355
  • [28] Susceptibility to Breast Cancer and Three Polymorphisms of GSTZ1
    Saadat, Iraj
    Khalili, Maryam
    Nafissi, Samane
    Omidvari, Shahpour
    Saadat, Mostafa
    DNA AND CELL BIOLOGY, 2012, 31 (03) : 336 - 340
  • [29] The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome
    Sa-nguanraksa, Doonyapat
    Thasripoo, Cholladda
    Samarnthai, Norasate
    Kununalue, Tanawan
    Thumrongtaradol, Thanawat
    O-charoenrat, Pornchai
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6344 - 6353
  • [30] Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility
    Treeck, Oliver
    Elemenler, Esma
    Kriener, Christina
    Horn, Felicitas
    Springwald, Anette
    Hartmann, Arndt
    Ortmann, Olaf
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 114 (3-5) : 207 - 211